

If you have room in your portfolio for some new additions, then you might want to consider the two ASX shares listed below.
Both have recently been named among the best ideas list of one of Australiaâs leading brokers, Morgans. Hereâs why its analysts are bullish on these ASX shares:
Healius Ltd (ASX: HLS)
The first ASX share that Morgans rates highly is healthcare company Healius. While COVID testing has clearly peaked, its analysts believe the company will still benefit from some level of testing and also a backlog in diagnosis and surgery. In addition, the broker has previously highlighted Healiusâ strong balance sheet, which provides it with opportunities to boost its earnings inorganically. Morgans commented:
Healius engages in the provision of healthcare technology solutions. It operates through the following segments: Medical Centres Bulk Billing, Pathology, Imaging, and Medical Centres Private Billing. [â¦] As COVID uncertainty remains, we believe the company looks well placed to not only benefit from a likely âbaseloadâ of COVID PCR testing going forward, but also from any rebound in demand from the backlog in diagnosis and surgery as the country opens up.
The broker has an add rating and $4.50 price target on Healiusâ shares.
IDP Education Ltd (ASX: IEL)
Morgans appears to believe that this student placement and language testing company could be a great long term pick for investors. And while it acknowledges that its shares are not conventionally cheap, it does see value in them considering its expectation for a two-year earnings per share compound annual growth rate of 38.2%. It commented:
IEL’s recovery (Australia Student Placement) and momentum (other divisions) support the strong growth expected in FY23. Structural demand, market share gains, technology-led client retention, operating leverage and acquisitions (especially IELTs distribution) can see IEL compound growth long-term. Value has emerged, however IEL’s near-term multiples see the stock susceptible to short-term volatility.
Morgans has an add rating and $31.10 price target on IDP Educationâs shares.
The post Broker names 2 of the best ASX shares to buy now appeared first on The Motley Fool Australia.
Wondering where you should invest $1,000 right now?
When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for over ten years has provided thousands of paying members with stock picks that have doubled, tripled or even more.* Scott just revealed what he believes could be the “five best ASX stocks” for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now
See The 5 Stocks
*Returns as of August 4 2022
(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()
More reading
- ‘Unparalleled’: 2 experts reckon this ASX share is a long-term buy
- 2 ASX 200 shares named as buys by a top broker
- 2 ASX shares that look expensive but have years of growth ahead: QVG Capital
- 5 things to watch on the ASX 200 on Wednesday
- These 9 ASX 200 shares are going ex-dividend tomorrow
Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Idp Education Pty Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
from The Motley Fool Australia https://ift.tt/h6pgduq
Leave a Reply